Correction to Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials
- PMID: 39300731
- PMCID: PMC11413056
- DOI: 10.1111/cts.70026
Correction to Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials
Erratum for
-
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials.Clin Transl Sci. 2024 Aug;17(8):e13874. doi: 10.1111/cts.13874. Clin Transl Sci. 2024. PMID: 39077906 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
